Journal article
Interleukin-6, cortisol, and depressive symptoms in ovarian cancer patients
Journal of clinical oncology, Vol.26(29), pp.4820-4827
10/10/2008
DOI: 10.1200/JCO.2007.14.1978
PMCID: PMC2653140
PMID: 18779606
Abstract
Inflammatory processes have been implicated in the pathogenesis of both depression and cancer. Links between depressive symptoms, interleukin-6 (IL-6), and cortisol dysregulation have been demonstrated in cancer patients, but vegetative versus affective components of depression have been minimally examined. The objective of the current study was to examine associations between IL-6, diurnal cortisol rhythms, and facets of depression in epithelial ovarian cancer patients.
Patients awaiting surgery for a pelvic mass suspected for ovarian cancer completed questionnaires, collected salivary samples for 3 days presurgery, and gave a presurgical blood sample. Ascites was obtained during surgery. IL-6 was measured by enzyme-linked immunosorbent assay and cortisol by a chemiluminescence immunoassay. The final sample included 112 invasive ovarian cancer patients (86 advanced stage, 26 early stage) and 25 patients with tumors of low malignant potential (LMP).
Advanced-stage ovarian cancer patients demonstrated elevations in vegetative and affective depressive symptoms, plasma IL-6, and the cortisol area under the curve (AUC) compared with patients with LMP tumors (all P < .05). Among invasive ovarian cancer patients, greater vegetative depression was related to elevated IL-6 in plasma (P = .008) and ascites (P = .024), but affective depression was unrelated to IL-6. Elevations in total depression (P = .026) and vegetative depression (P = .005) were also related to higher evening cortisol levels. Plasma IL-6 was related to greater afternoon and evening cortisol and cortisol AUC (all P values < .005).
These results demonstrate significant relationships between IL-6, cortisol, and vegetative depression, and may have implications for treatment of depression in ovarian cancer patients.
Details
- Title: Subtitle
- Interleukin-6, cortisol, and depressive symptoms in ovarian cancer patients
- Creators
- Susan K Lutgendorf - Department of Psychology, University of Iowa, Iowa City, IA 52242, USA. susan-lutgendorf@uiowa.eduAliza Z WeinribFrank PenedoDaniel RussellKoen DeGeestErin S CostanzoPatrick J HendersonSandra E SephtonNicolas RohlederJoseph A Lucci IIISteven ColeAnil K SoodDavid M Lubaroff
- Resource Type
- Journal article
- Publication Details
- Journal of clinical oncology, Vol.26(29), pp.4820-4827
- DOI
- 10.1200/JCO.2007.14.1978
- PMID
- 18779606
- PMCID
- PMC2653140
- NLM abbreviation
- J Clin Oncol
- ISSN
- 0732-183X
- eISSN
- 1527-7755
- Publisher
- United States
- Grant note
- R01 CA104825 / NCI NIH HHS CA104825 / NCI NIH HHS CA88293 / NCI NIH HHS
- Language
- English
- Date published
- 10/10/2008
- Academic Unit
- Psychological and Brain Sciences; Iowa Neuroscience Institute; Obstetrics and Gynecology; Urology
- Record Identifier
- 9984065880602771
Metrics
14 Record Views